Traditional methods for selection and cloning are often regarded as the main bottleneck in the development of cell lines for antibody and recombinant protein production. ClonaCell®’s methylcellulose-based semi-solid media and its automated platform, the ClonaCell® EasyPick, address these limitations by offering quality, speed, and throughput in the generation of cell lines.
Custom formulations of ClonaCell® are available to meet individual needs for the selection and cloning of mammalian cells.
Hybridoma generation
Transfected cell selection
ClonaCell® EasyPick automated platform for cell line generation
ClonaCell
® EasyPick is a fully automated platform for cell line generation that merges the rapid selection and cloning of cells using ClonaCell
® media with Hamilton’s 30 years of experience in robotics to meet the three most important aspects of developing cell lines for biologics production: speed, throughput, and quality.
- SPEED. Generate stable cell lines in as little as 14 days by combining selection and cloning using ClonaCell® media.
- THROUGHPUT. Isolate up to 300 clones per hour in a fully automated environment.
- QUALITY. Increase the probability of isolating rare high-yield clones with ClonaCell® media.